cryptocurrency about- Top Knowledge

Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Japanese and Korean stock markets opened lower, with the Nikkei 225 index down 0.56% at 39,624.05. South Korea's KOSPI index opened down 0.3% to 2,473.75 points.The UN Secretary-General is deeply concerned about the extensive violation of Syrian sovereignty. On the 12th, UN Secretary-General Guterres issued a statement through spokesman Dujaric, expressing deep concern about the recent extensive violation of Syrian sovereignty and territorial integrity, especially the hundreds of Israeli air strikes against Syria. The statement said that the Disengagement of Forces Agreement signed in 1974 is still valid. Guterres condemned all violations of the agreement and called on all parties to fulfill their relevant obligations, including ending all unauthorized presence in the isolation zone and avoiding any actions that undermine the ceasefire and stability in the Golan Heights. (Xinhua News Agency)

Guotai Junan: It is suggested that the beauty care sector with product and channel changes and flexibility should be optimized from the bottom up. Guotai Junan said that after the pressure of consumption in 2022 and the destocking of consumers in 2023, the beauty consumption will return to the normal purchase cycle in 2024, and the industry prosperity will improve month-on-month, and the double-digit growth of online beauty will be achieved. However, after the channel dividend subsided, the platform traffic and price competition became fierce, and the brand differentiation further intensified. Relying on the product innovation and channel operation ability brought by organizational efficiency, the performance of domestic products in the head is still bright, and the rise of new domestic products has spread from beauty cosmetics to personal care. Looking forward to 2025, the market risk appetite will be significantly restored. Because of its many changes and the rising trend of domestic products as a whole, the American nursing sector has obvious growth attributes and significantly benefited from its style. Brand differentiation in the fundamental dimension has intensified, and it is suggested that the flexible target with product and channel changes should be optimized from bottom to top.New Zealand wants to persuade the United States not to impose tariffs after Trump takes office. New Zealand Finance Minister Nicola Willis said that after US President-elect Donald Trump takes office, New Zealand should be exempted from imposing comprehensive tariffs, and asked officials to be sensible to the United States. "Our initial position was please don't do this," Willis said in an interview in Wellington. "We let diplomats show the best of New Zealand."After the short-term survey was released, the 10-year Japanese government bond futures rose to 142.51.

Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.US Congressman French Hill will take over as the chairman of the House Financial Services Committee. On December 12, local time, the reporter learned that French Hill, a Republican congressman and former banker from Arkansas, will be the next chairman of the House Financial Services Committee. The Financial Services Committee of the House of Representatives is an important body of the US Congress, which is responsible for supervising the financial industry and formulating relevant legislation. Its responsibilities cover banking, the overall financial system and the cryptocurrency market. Hill will succeed retiring Patrick Patrick McHenry, whose formal appointment is expected to be approved by the Republican Party in the next few days. (CCTV)In the first 11 months of GEM, the scale of raising funds by issuing 34 new shares dropped significantly year-on-year. Statistics show that from January to November, 2024, there were 34 new shares listed on GEM, with a total amount of raised funds of about 20.174 billion yuan. The number of issues and the scale of raising funds decreased by about 67% and 83% respectively year-on-year, and the number of listed new shares declined for three consecutive years. Among them, Nova Nebula and Yilian Technology have raised a total of more than 1 billion yuan, which is on the top. The share prices of the first-time shares of GEM all rose on the first day of listing, among which Changlian Technology and Shangda Shares rose more than 1000% on the first day of listing. In addition, there are 17 new shares listed income increased by more than 200%. In terms of underwriters, in the first November of 2024, the number of main underwriting projects of CITIC Jiantou, Guotai Junan and CICC was in the top three. Judging from the scale of fundraising, the total number of projects underwritten by Minsheng Securities and CITIC Jiantou exceeds 2.5 billion yuan, and the project scale of China Merchants Securities, Huatai United Securities and Guotai Junan exceeds 1.5 billion yuan. (Xinhua Finance)